What powers aginganddisease.org?
Last seen Jun 2026 · 9 technologies across 9 categories
CDN
Font scripts
Hosting
JavaScript graphics
JavaScript libraries
Miscellaneous
Programming languages
UI frameworks
Webmail
Top search keywords
| Keyword | Position | Est. monthly visits |
|---|---|---|
| aging dis | #1 | 79 |
| increased vascular permeability | #4 | 58 |
| cerebral small vessel disease | #8 | 47 |
| small vessel disease | #14 | 37 |
| aging disease | #5 | 28 |
| best anti inflammatory supplements | #12 | 27 |
| small vessel ischemic disease | #18 | 27 |
| ependymal cells function | #9 | 24 |
| reflex seizures | #7 | 23 |
| pde5i | #6 | 17 |
| sirt6 | #5 | 15 |
| aging impact factor | #5 | 15 |
| vascular permeability | #8 | 14 |
| is a high riding jugular bulb dangerous | #5 | 12 |
| ossification of the posterior longitudinal ligament | #17 | 10 |
| central fatigue | #6 | 9 |
| balance and elderly | #4 | 9 |
| anti inflammatory vitamins | #13 | 8 |
| define sarcopenic obesity | #5 | 8 |
| balance and old age | #5 | 7 |
| seniors balance problems | #14 | 7 |
| anserine supplement | #3 | 7 |
| masa the mann assessment of swallowing ability | #7 | 7 |
| age related diseases | #12 | 7 |
| erythrocyte lifespan | #7 | 7 |
The site's top keywords in Google (US), with the visits each one is estimated to bring per month.
Top backlinks
Top links pointing at the site, one per source domain, strongest first. The anchor text opens the page carrying the link.
Audience
- 79% desktop
- 21% phone
United Kingdom
France
Canada
Spain
South Korea
United States
Countries where the site has Chrome traffic, strongest markets first.
Open Page Rank
6.17 / 10 · ranked #99,016 of all domains
359 referring domains · OpenPageRank
Search traffic
840 est. monthly organic visits (US)
802 keywords in Google's top 30
Core Web Vitals
| LCP | 5.1 s |
| INP | 50 ms |
| CLS | 0.15 |
| TTFB | 1900 ms |
Real user p75, Chrome UX Report, Jun 2026.
Page
- CDN: Sucuri Firewall
- Weight: 10.2 MB · 52 requests
Homepage as crawled by the HTTP Archive, Jul 2026.